India to Brazil: Apixaban Export Trade Route
India has recorded 270 verified shipments of Apixaban exported to Brazil, representing a combined trade value of $14.1M USD. This corridor is served by 13 active Indian exporters, with an average shipment value of $52.3K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED , which accounts for 26% of total export value with 45 shipments worth $3.6M USD. On the buying side, BRAINFARMA INDUSTRIA QUIMICA E is the largest importer in Brazil with $3.2M USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED , ZYDUS LIFESCIENCES LIMITED, NATCO PHARMA LIMITED — together control 70% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Brazil Apixaban corridor is one of India's established pharmaceutical export routes, with 270 shipments documented worth a combined $14.1M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED , which alone accounts for roughly 26% of all export value, reflecting the consolidated nature of India's apixaban manufacturing sector.
Across 13 active suppliers, the average shipment value stands at $52.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Freight is split between sea (67%) and air (17%), suggesting a mix of scheduled bulk orders and time-sensitive consignments.
Shipment activity peaks during April–June, with an average transit time of 15 days port-to-port. The route has recorded an annual growth rate of 18.6%, placing it at rank #18 among India's top apixaban export destinations globally.
On the import side, key buyers of Indian apixaban in Brazil include BRAINFARMA INDUSTRIA QUIMICA E , BRAINFARMA INDUSTRIA QUIMICA E, NATCOFARMA DO BRASIL LTDA and 29 others. BRAINFARMA INDUSTRIA QUIMICA E is the single largest importer with 31 shipments valued at $3.2M USD.
